financetom
Business
financetom
/
Business
/
Why Is Agape ATP Stock Jumping Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is Agape ATP Stock Jumping Today?
Sep 13, 2024 12:12 PM

Agape ATP Corporation ( ATPC ) shares are trading higher after the company announced it entered into a strategic collaboration with Xiamen Photons Solar Technology, focusing on developing solar photovoltaic mounting systems for Malaysia and ASEAN countries.

The company’s subsidiary, ATPC Green Energy, has formed a strategic collaboration with Xiamen Photons Solar Technology, a value chain partner of Fujian Minfa Aluminium Co., which is listed on the Shenzhen Stock Exchange.

The agreement was signed at Photons Solar’s headquarters in Xiamen, China.

Also Read: Oracle Quietly Gains Momentum While Nvidia, Meta Dominate AI Spotlight

This partnership is timely as ASEAN nations enhance their commitment to a zero-carbon energy future. Regional governments are actively implementing policies to promote renewable energy development and carbon neutrality.

The collaboration between Photons Solar and ATPC Green Energy aims to accelerate these initiatives and drive the transformation of the ASEAN solar market.

How Kok Choong, founder and global group CEO of ATPC, indicated that the collaboration with Photons Solar represents a significant advancement in their efforts to develop solar PV farms in Sabah.

The partnership is expected to tackle key challenges like grid stability and power supply issues, supporting Sabah’s transition to clean and reliable energy.

“This partnership allows us to leverage local insights and advanced technologies, further supporting our commitment to advancing renewable energy goals across the region,” the CEO added.

Price Action: ATPC shares are trading higher by 84.1% to $2.67 at last check Friday.

Read Next:

Nvidia Analyst Praises Huang’s Insight That Hyperscale Customers Earn ‘$5 In Rental Revenue For Every $1 Spent’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Allete Enters Agreement To Be Acquired By A Partnership Led By Canada Pension Plan Investment Board And Global Infrastructure Partners To Advance 'Sustainability-In-Action' Strategy
BRIEF-Allete Enters Agreement To Be Acquired By A Partnership Led By Canada Pension Plan Investment Board And Global Infrastructure Partners To Advance 'Sustainability-In-Action' Strategy
May 6, 2024
May 6 (Reuters) - ALLETE Inc ( ALE ): * ALLETE ENTERS AGREEMENT TO BE ACQUIRED BY A PARTNERSHIP LED BY CANADA PENSION PLAN INVESTMENT BOARD AND GLOBAL INFRASTRUCTURE PARTNERS TO ADVANCE 'SUSTAINABILITY-IN-ACTION' STRATEGY * ALLETE INC ( ALE ): SHAREHOLDERS TO RECEIVE $67.00 PER SHARE IN CASH * ALLETE INC ( ALE ): PROPOSED DEAL FOR $6.2 BILLION *...
KKR Goes Surgical: Snags Indian Medical Devices Company Healthium From Apax
KKR Goes Surgical: Snags Indian Medical Devices Company Healthium From Apax
May 6, 2024
KKR & Co. Inc. ( KKR )  announced the signing of definitive agreements to acquire Healthium Medtech Ltd. from an affiliate of Funds advised by Apax Partners LLP. Financial details were not disclosed. Based in India, Healthium is a medical devices company that develops, manufactures, and sells a broad range of surgical products worldwide. Akshay Tanna, Partner and Head of India Private Equity at KKR, said: “Under the...
Spirit Airlines forecasts weak Q2 revenue on slow growth in domestic demand
Spirit Airlines forecasts weak Q2 revenue on slow growth in domestic demand
May 6, 2024
May 6 (Reuters) - Spirit Airlines ( SAVE ) forecast weak second-quarter revenue on Monday due to sluggish improvement in domestic demand and grounding of dozens of its aircraft. The airline is among the most heavily impacted by issues with RTX's Pratt & Whitney Geared Turbofan engines, which have forced it to ground multiple aircraft and resulted in high labor...
Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib
Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib
May 6, 2024
07:43 AM EDT, 05/06/2024 (MT Newswires) -- Redhill Biopharma ( RDHL ) said Monday it was awarded a new patent in China for investigational drug opaganib as a therapy to inhibit single-stranded RNA virus replication, notably Ebola virus disease. The patent, issued by the Chinese National Intellectual Property Administration, is valid through 2035, according to Redhill. The company said opaganib...
Copyright 2023-2025 - www.financetom.com All Rights Reserved